808 - Process Development and Manufacturing: RELEASE TESTING OF GMP MANUFACTURED CELLTHRPE1 FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.

MLA

Vidal, L.Baque, et al. “808 - Process Development and Manufacturing: RELEASE TESTING OF GMP MANUFACTURED CELLTHRPE1 FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.” Cytotherapy (Elsevier Inc.), vol. 25, no. 6, May 2023, p. S170. EBSCOhost, https://doi.org/10.1016/S1465-3249(23)00455-3.

APA

Vidal, L. B., Main, H., Reilly, H., Hedenskog, M., Beri, N., Metzger, H., Saietz, S., Berggren, S., Holm, A., Eistrand, U., Wrona, A., von Halling Laier, C., Efstathopoulos, P., Jaberi, E., Willenbrock, H., Shimizu, Y., Galler, G., Elefante, F., Jensen, L. B., & Nielsen, K. (2023). 808 - Process Development and Manufacturing: RELEASE TESTING OF GMP MANUFACTURED CELLTHRPE1 FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION. Cytotherapy (Elsevier Inc.), 25(6), S170. https://doi.org/10.1016/S1465-3249(23)00455-3

Chicago

Vidal, L. Baque, H. Main, H. Reilly, M. Hedenskog, N. Beri, H. Metzger, S. Saietz, et al. 2023. “808 - Process Development and Manufacturing: RELEASE TESTING OF GMP MANUFACTURED CELLTHRPE1 FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.” Cytotherapy (Elsevier Inc.) 25 (6): S170. doi:10.1016/S1465-3249(23)00455-3.